Neuropathological Characteristics of Progression after Prolonged Response to Bevacizumab in Multifocal Hemangioblastoma

Publisher： Karger

E-ISSN： 2296-5262|37|4|209-212

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.37, Iss.4, 2014-03, pp. : 209-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 72-77

Karger

Access to resources Recommend Favorite

Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 639-643

Karger

Access to resources Recommend Favorite

MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 12, 2015-06 ,pp. : 2844-2853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complete response to induction therapy in patients with Myc‐positive and double‐hit non‐Hodgkin lymphoma is associated with prolonged progression‐free survival

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1677-1685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-04 ,pp. : 169-172

Karger

Access to resources Recommend Favorite